![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 26, 2021 10:24:46 AM
FDA should take these new variants into consideration as part of the risk with not giving Lenz an EUA. The scale should tip towards Lenz where reward is greater than the risk. And hopefully additional data does the same.
Yep, lenz being variant agnostic should make an authorizations by the MHRA and FDA a no-brainer. Lenz's safety data is sparkling clean so any potential risks are solely theoretical. This winter is going to have 2 bad waves. First will be the Delta winter that we've already entered and then an even worse Nu winter. Nu's devastating potential should help sway government opinion in lenz's favor.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM